GeneDx Holdings Corp. updated earnings guidance for the year 2024. For the year, the company now expects revenues to be between $235 million and $245 million (previous guidance was $220 million to $230 million).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.8 USD | +6.04% | +0.83% | +652.73% |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+652.73% | 513M | |
-24.66% | 7.76B | |
+69.23% | 4.33B | |
-3.33% | 2.64B | |
+3.74% | 2.63B | |
-47.63% | 2.16B | |
-16.41% | 1.75B | |
-19.68% | 1.46B | |
+14.52% | 1.17B | |
-45.53% | 1.14B |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- GeneDx Holdings Corp. Updates Earnings Guidance for the Year 2024